top of page

Has a Revolutionary Weight-loss Drug Finally Been Discovered?

Mounjaro - A Type II Diabetes Medication that shows potential to help people lose up to 20% of their body weight with minimal side-effects.



If you could take a magic pill that had minimal side-effect and could help you reach your weightless goals without feeling hangry - would you take it? I think the vast majority of people would say "heck yeah" without giving it much thought.


Millions of Americans are on a miserable, calorie restricting diet that might work for a few months but ultimately over time ends up causing more weight gain than weight loss. Diets don't work but making lifestyle changes also isn't easy!


Wouldn't it be nice to just take a weekly pill or shot that painlessly helped you shed those extra pounds?


There might just be such a drug out there but it currently only FDA approved to help combat the symptoms of type ll diabetes. It is called Tirzepatide (Mounjaro is the market name) and it has shown potential to be a very effective weight-loss drug.


Rumor has it that many celebrities who do not have type ll diabtes and have recently displayed significant weightless have been taking Mounjaro or similar drugs. Khloe Kardashian recently disputed such an accusation on her Instagram account because of her significant weight-loss in recent months. There is no doubt growing interest and off-label use of Mounjaro as a weightless drug in certain circles.



SO, IS MOUNJARO AN EFFECTIVE AND SAFE WEIGHT-LOSS SOLUTION?

One trial testing the efficacy of Mounjaro as a weightless drug published in the New England Journal of Medicine enrolled 2,539 obese adults (weighing an average of 231 pounds with a body mass index (BMI) of 38 to start. Over a timespan of 72 weeks, the participants were randomly assigned once-weekly injections of placebo or one of three doses of tirzepatide (Mounjaro) — 5 mg, 10 mg, or 15 mg.


The participants who received the highest dose lost an average of 20.9 percent of their body weight by the end of the trial, or about 52 pounds. On average the 10mg dose group lost 49 pounds and 35 pounds, among the 5 mg dose group.


These results are remarkable and could be the beginning of a huge shift in how obesity is treated in the near future.


However, since there is a lack of FDA approval regarding the usage of Mounjaro for weight-loss, it is not recommended to depend on it for this purpose if you have not been diagnosed with type ll diabetes.


Given the data so far, such an effective drug with mild side effects will most likely soon be approved as weight-loss agent.


Read a bit more about Mounjaro below!



MOUNJARO:


Mounjaro is the market name for Tirzepatide. It is also an injectable form of anti-hyperglycemic drug that helps people maintain their blood glucose levels within the optimal ranges. Mounjaro is given at a once-weekly dosage in diabetic people.

Mounjaro is a relatively recent drug and therefore, not much research has been done on its safety profile. There is still a lot that needs to be discovered about this drug, especially regarding weightless and dosing in children.


SIDE EFFECTS AND RISKS:


It is recommended that people with kidney and liver problems and children under the age of 18 years do not use this injection.


However, apart from that, the most common side effects of using Mounjaro include:

  • Decreased Appetite (a major factor in why patients lost so much weight)

  • Abdominal Pain

  • Vomiting

  • Indigestion



CONCLUSION


Although there are more and more people using Mounjaro, off-label, as a weightless drug - it still has not been approved as such by the FDA and must undergo further research before I would recommend it to any of you.


That being said, the prospect of a drug coming on he market that is safe and effective at helping millions of overweight and obese Americans lose a substantial amount of weight - is very exciting.


I will definitely be keeping a close look at new research that comes out regarding this class of drugs and their safety and efficacy as weightless drugs!


Until next time,


Alexes Hazen Md


11 views0 comments